Loading TickerWise...

APUS — Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc. operates as a clinical stage biopharmaceutical company in the United States. It researches, develops, manufactures, commercializes, and sells Apitox, an active pharmaceutical ingredient for the treatment of inflammation and pain management symptoms associated with osteoarthritis and multiple sclerosis. The company was incorporated in 2020 and is based in Hopewell, New Jersey. Apimeds Pharmaceuticals US, Inc. is a subsidiary of Api Meds, Inc.

Company profile

Latest SEC filings for APUS

Latest APUS news

Abrir análisis completo

Educational tool only — not investment advice.